Pharos iBio (388870) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩316M ($220K) in reported transaction value. The earliest filing StockDrifts holds for Pharos iBio is dated 2024-09-27; the most recent is 2026-06-04. Across these filings the average return since disclosure is +22.26%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | BUY | Market Buy | 윤정혁 Jeonghyeok Yoon | CEO | 15.0K | ₩6,300 | +24.1% | ₩95M ($66K) |
| 2026-01-09 | SELL | 임원퇴임 | HAN HYE JUNG | president | -240.0K | ₩10,350 | +20.3% | ₩2.5B ($1.7M) |
| 2025-07-16 | BUY | Market Buy | 김규태 Kim Gyu-tae | vice president | 12.5K | ₩6,230 | +32.4% | ₩78M ($54K) |
| 2025-07-14 | BUY | Market Buy | 윤정혁 Jeonghyeok Yoon | CEO | 8.3K | ₩5,910 | +39.6% | ₩49M ($34K) |
| 2024-09-27 | BUY | Market Buy | 윤정혁 Jeonghyeok Yoon | CEO | 10.7K | ₩8,880 | -7.1% | ₩95M ($66K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.